CLINICAL_TRIALS
trial_result
· 2022-09-01
Clinical Trial Update: Sorafenib Long Term Extension Program [Phase 3]
Summary
A Phase 3 long-term extension trial update for sorafenib in neoplasms has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2022-09-01